ReachMD CME

Por: ReachMD
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
379 episodios disponibles

Latest episodes of the podcast ReachMD CME

Mostrando página 18 de 19

Adjuvant Treatments for HR+/HER2- EBC: The Role of CDK4/6 and PARP Inhibitors 30/12/2024
Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC 30/12/2024
The Role of HER2-Directed Therapy for Second-Line Treatment of HER2+ Metastatic Breast Cancer 30/12/2024
Guideline Recommendations for the Definition and Treatment of HER2-Low Breast Cancer 30/12/2024
Emerging Treatment Approaches for EBC 30/12/2024
The Evolving Treatment Landscape for MBC: Emerging Therapies 30/12/2024
Expert Viewpoint: Optimizing Breast Cancer Treatment 30/12/2024
Management of HR+, HER2- High-Risk EBC 30/12/2024
Management of HER2-Low MBC Following First-Line Disease Progression 30/12/2024
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence 30/12/2024
The Role of Biomarker-Driven Therapies in the Second-Line Treatment of Advanced Gastric/GEJ Cancers: What Do the Data Say? 30/12/2024
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study 30/12/2024
Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence 30/12/2024
First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy 30/12/2024
Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC 30/12/2024
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion 30/12/2024
Emerging Directions in Biomarker-Directed Therapy for GI Malignancies 30/12/2024
Novel Neoadjuvant and Adjuvant Immunotherapy Strategies for GI Malignancies: The Evidence 30/12/2024
Expert Opinion: Key Insights on GI Malignancies—Integrating NCCN Clinical Practice Guidelines Into Practice 30/12/2024
ns-MRAs and Biomarkers: The NT-proBNP Connection 10/01/2025
« Primera ‹ Anterior 1 ... 16 17 18 19 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA